2nd Circ. OKs $5M Deal In Telik Cancer Drug Suit
The U.S. Court of Appeals for the Second Circuit issued a summary order Monday backing the district court’s September 2008 approval of the settlement and making quick work of shareholder Andrew R. May’s appeal.
Pointing out that significant deference is due the judge who oversaw the class action litigation...
To view the full article, register now.